Trial Profile
An open label, dose escalation phase I study of the safety, pharmaccodynamics and pharmacokinetics of ATN-224 capsules in patients with advanced hematological malignancies
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2006
Price :
$35
*
At a glance
- Drugs Tiomolibdate choline (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 18 Jan 2006 New trial record.